HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelial cell activation and hypercoagulability in ocular Behçet's disease.

AbstractPURPOSE:
To investigate the presence of a hypercoagulable state and vascular endothelial dysfunction in patients with ocular Behçet's disease and relate the results to the activity of ocular and systemic involvement.
DESIGN:
Cross-sectional laboratory and clinical study.
METHODS:
Prospective study of blood samples of 24 patients diagnosed with ocular Behçet's disease, which were analyzed for factor VIII, factor XI, von Willebrand factor antigen and ristocetin (vWF ag and risto), antithrombin III (ATIII), protein C and S, fibrinogen and activated protein C (APC) resistance. The results were compared with 40 healthy controls and analyzed for association with ocular and systemic clinical features.
RESULTS:
The mean values of factor VIII, factor XI, vWF ag, vWF risto, ATIII, and fibrinogen were significantly raised compared to healthy population (for all: P <.001). Most striking were factor VIII activity levels above 130% in 79% (19 of 24) of our patients. 67% (16 of 24) had levels of factor VIII above 150%, which correlates with a fivefold increase in risk of thrombosis. Other prothrombogenic factors were negative in all but 2 patients (1 protein C deficiency, 1 factor V Leiden mutation). Endothelial cell activation, measured by vWF activity, revealed elevated levels in 42% (10/24). Complete/incomplete Behçet's disease patients with present or previous macular edema had significantly higher FVIII levels than complete/incomplete Behçet's disease patients who had never shown any signs of macular edema (P =.04). Further correlations between the laboratory results and clinical symptoms were not found.
CONCLUSIONS:
We found a generalized hypercoagulable state with endothelial cell activation in ocular Behçet's disease, irrespectively of current ocular disease activity.
AuthorsKiki Probst, Rob Fijnheer, Aniki Rothova
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 137 Issue 5 Pg. 850-7 (May 2004) ISSN: 0002-9394 [Print] United States
PMID15126149 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • Protein C
  • Protein S
  • Von Willebrand antigen
  • von Willebrand Factor
  • Ristocetin
  • Antithrombin III
  • Factor VIII
  • Fibrinogen
Topics
  • Activated Protein C Resistance (blood)
  • Adult
  • Antigens (analysis)
  • Antithrombin III (analysis)
  • Behcet Syndrome (blood, complications)
  • Cross-Sectional Studies
  • Endothelium, Vascular (pathology)
  • Factor VIII (analysis)
  • Female
  • Fibrinogen (analysis)
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Protein C (analysis)
  • Protein S (analysis)
  • Ristocetin (analysis)
  • Thrombophilia (blood, complications)
  • Venous Thrombosis (blood, complications)
  • von Willebrand Factor (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: